Joshua Lennon, MD
Neurology · Cordova, TNNPI 1427369172
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 56.7% of the total. Reporting peaked in 2023 at $3,948 and has fallen 91.4% since, to $338 in 2025.
Across 78 payments — averaging $145.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$6K
- ZOLL Respicardia, Inc.$2K
- Inspire Medical Systems, Inc.$1K
- Harmony Biosciences LLC$249
- Resmed Corp$240
- Avadel CNS Pharmaceuticals, LLC$187
- plus $811 from 13 others
Across 117 payments — averaging $2665.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$105K
- Jazz Pharmaceuticals Inc.$102K
- Harmony Biosciences LLC$61K
- Alkermes, Inc.$43K
What the payments were for
- Consulting fees$5,94353%
- Travel & lodging$2,11419%
- Food & beverage$2,82925%
- Education$1902%
- Gifts$2402%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 10 | $6,416 |
| ZOLL Respicardia, Inc. | 5 | $2,120 |
| Inspire Medical Systems, Inc. | 8 | $1,293 |
| Harmony Biosciences LLC | 8 | $249 |
| Resmed Corp | 1 | $240 |
| Avadel CNS Pharmaceuticals, LLC | 6 | $187 |
| EMD Serono, Inc. | 10 | $181 |
| Novartis | 6 | $89 |
| F. Hoffmann-la Roche AG | 1 | $80 |
| Sunovion Pharmaceuticals Inc. | 6 | $76 |
| Amgen | 4 | $75 |
| AbbVie | 4 | $74 |
| Insightec,inc | 1 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $39 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Mallinckrodt Enterprises LLC | 2 | $29 |
| Cycle Pharmaceuticals Inc | 2 | $28 |
| Nevro Corp. | 1 | $23 |
| Boston Scientific | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XYWAV$5,943
- remede System$2,051
- Inspire Upper Airway Stimulation System$954
- AirSense$240
- Inspire$239
How this compares
$11,316 in reported general payments places this provider in the 65th percentile of 361 neurology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Cordova
- Lee SteinCordova$213K
- Kendrick HendersonCordova$28K
- David PritchardCordova$27K
- Oleksandra DrynCordova$26K
- Samuel HunterSpring Hill$676K
- Harold MosesNashville$438K
- Lucas ElijovichMemphis$415K
- David BrandesKnoxville$412K
- Sibyl WrayKnoxville$377K
- Christine HagenAlcoa$371K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.